{
  "ptid_time": "127_S_0259_2012-04-02",
  "img_path": "/data/qiuhui/data/adni/images/127_S_0259/2012-04-02/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 49,647 mm³, 28.9% above the reference mean. With a Z-score of 0.69 (75.6th percentile), this represents normal volume ; hippocampal volume measures 5,449 mm³, 27.9% below the reference mean. With a Z-score of -2.72 (0.3th percentile), this represents significant atrophy; whole brain volume measures 806,569 mm³, 25.3% below the reference mean. With a Z-score of -3.28 (0.1th percentile), this represents profound atrophy; entorhinal cortex volume measures 2,753 mm³, 32.9% below the reference mean. With a Z-score of -2.23 (1.3th percentile), this represents significant atrophy; fusiform gyrus volume measures 13,917 mm³, 26.1% below the reference mean. With a Z-score of -2.23 (1.3th percentile), this represents significant atrophy; middle temporal gyrus volume measures 15,220 mm³, 28.7% below the reference mean. With a Z-score of -2.58 (0.5th percentile), this represents significant atrophy. ",
  "text_data": "Age is 76.6 years. Gender is Male. Education: 20 years. MMSE: 28.0. MoCA: 22.0. Logical Memory: 16.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the hippocampus, entorhinal cortex, fusiform gyrus, and middle temporal gyrus, along with profound whole-brain atrophy, all of which are strongly associated with Alzheimer's pathology. Despite the high MMSE score (28/30), the MoCA score (22/30) suggests mild cognitive impairment, particularly in executive function and memory domains. The absence of APOE4 does not rule out Alzheimer's, as neurodegeneration patterns are more diagnostically significant.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal Alzheimer’s given the atrophy pattern).  \n**Confidence:** **High** (due to clear structural deficits and MoCA findings, though MMSE is less sensitive).  \n\n*Note: Progression to dementia is likely if atrophy and cognitive decline continue at this rate. Follow-up with CSF biomarkers or amyloid PET could further clarify etiology.*",
  "timestamp": "2025-07-26T12:57:09.876191"
}